The Column Group (TCG)

The Column Group (TCG) is a venture capital firm focused on building early stage drug discovery companies based on unique scientific platforms and potential breakthrough therapeutics. Their investment strategy emphasizes long-term value generation and the development of fundamentally strong companies built on great science and the ability to generate multiple differentiated product opportunities.

TCG's approach is centered on the bold pursuit of big ideas using innovative science to address significant diseases, and they are committed to all facets of company building and bringing together scientific, financial, and operational expertise to shape promising science into a value-rich portfolio poised to have a profound impact on human health.